ReviewResearch and reports in urology2026

Sequential Intravesical Gemcitabine and Docetaxel for Non-Muscle Invasive Bladder Cancer: A Narrative Review Across Risk Groups.

Mahdi Hemmati Ghavshough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.